SCHEMBL4936330

SCHEMBL4936330

CNc1nccc(Oc2ccc(NC(=O)Nc3ccc(CN4CCN(C(C)C)CC4)c(C(F)(F)F)c3)cc2)n1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 7/20 0.68
CDK2 P24941 2/20 0.68
CDK1 P06493 1/20 0.68
SRC P12931 6/20 0.61
ABL1 P00519 6/20 0.61
MAPK14 Q16539 3/20 0.61
KDR P35968 3/20 0.61
RET P07949 3/20 0.61
MKNK1 Q9BUB5 3/20 0.61
MKNK2 Q9HBH9 3/20 0.61
MAP3K7 O43318 2/20 0.61
MAP4K2 Q12851 2/20 0.61
MAP3K20 Q9NYL2 2/20 0.61
BRAF P15056 2/20 0.61
TNNI3K Q59H18 2/20 0.61
FGFR4 P22455 2/20 0.61
BCR P11274 2/20 0.61
STK25 O00506 1/20 0.61
CIT O14578 1/20 0.61
MAP2K7 O14733 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4940425 0.90 CDK8 (0.69) CDK8CDK2CDK1SRCABL1
SCHEMBL4931472 0.90 CDK2 (0.84) CDK8CDK2CDK1SRCABL1
SCHEMBL13991162 0.89 CDK8 (0.68) CDK8CDK2CDK1SRCABL1
SCHEMBL13991080 0.85 MAPK14 (0.84) CDK8CDK2CDK1SRCABL1
SCHEMBL4936685 0.84 CDK8 (0.82) CDK8CDK2CDK1SRCABL1
SCHEMBL4933283 0.83 SRC (0.69) CDK8CDK2CDK1SRCABL1
SCHEMBL4936999 0.83 SRC (0.68) CDK8CDK2CDK1SRCABL1
Trifluoroacetic Acid SCHEMBL4929655 0.83 KDR (0.79) CDK8CDK2CDK1SRCABL1
SCHEMBL13991129 0.82 KDR (0.67) CDK8CDK2CDK1SRCABL1
SCHEMBL13991434 0.81 SRC (0.66) CDK8CDK2CDK1SRCABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US claimed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases RET, PRKDC, PRKACA CDK8 170/4885CDK2 83/4885CDK1 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.